Divining progression in Parkinson disease with a blood test: NfL

Affiliations

¹ From Bellevue Hospital (L.S.B.); New York University School of Medicine (L.S.B.); Albany-Stratton VA Medical Center, NY (L.S.B.); Essentia Health, Duluth, MN (L.S.B.); and "Rita Levi Montalcini" Department of Neuroscience (A.C.), University of Turin, Italy. laura.boylan@med.nyu.edu.
² From Bellevue Hospital (L.S.B.); New York University School of Medicine (L.S.B.); Albany-Stratton VA Medical Center, NY (L.S.B.); Essentia Health, Duluth, MN (L.S.B.); and "Rita Levi Montalcini" Department of Neuroscience (A.C.), University of Turin, Italy.

Free article

Editorial

Laura S Boylan et al. Neurology. 2019.

Free article

. 2019 Sep 10;93(11):471-472.

doi: 10.1212/WNL.0000000000008087. Epub 2019 Aug 16.

¹ From Bellevue Hospital (L.S.B.); New York University School of Medicine (L.S.B.); Albany-Stratton VA Medical Center, NY (L.S.B.); Essentia Health, Duluth, MN (L.S.B.); and "Rita Levi Montalcini" Department of Neuroscience (A.C.), University of Turin, Italy. laura.boylan@med.nyu.edu.
² From Bellevue Hospital (L.S.B.); New York University School of Medicine (L.S.B.); Albany-Stratton VA Medical Center, NY (L.S.B.); Essentia Health, Duluth, MN (L.S.B.); and "Rita Levi Montalcini" Department of Neuroscience (A.C.), University of Turin, Italy.

No abstract available

Comment on

Blood NfL: A biomarker for disease severity and progression in Parkinson disease.
Lin CH, Li CH, Yang KC, Lin FJ, Wu CC, Chieh JJ, Chiu MJ. Lin CH, et al. Neurology. 2019 Sep 10;93(11):e1104-e1111. doi: 10.1212/WNL.0000000000008088. Epub 2019 Aug 16. Neurology. 2019. PMID: 31420461